E-tendering

e-Tendering
{Procurement of Medicines}
Important notice to prospective vendors/bidders
registering with IREPS
Al the tenders of Indian Railways are being processed through E-Procurement System(IREPS) on the portal Like all others items, all the future tenders of Medicines are being planned to be uploaded on this portal very soon. Thereafter manual tenders wil not be invited.
Manual offers against e-Tenders shall be considered as invalid offers and shall be rejected summarily without any consideration.
Accordingly, it is necessary for all prospective bidders to be a registered user of IREPS website. Please visit IREPS website and see helpdesk menu or contact with CRIS, New Delhi at 011-24105180/24102855 for any help in getting registered with IREPS.
A Class III-B digital signature certificate is pre-requisite for registration at IREPS website. This certificate can be obtained from any of the licensed certifying agencies whose addresses are available on the website You are advised to get yourself registered with IREPS website and inform the details of same this office as early as possible. For controller of Store
Indian Railways
Diesel Locomotive Works
Varanasi-221004
MEDICAL BULLETIN- 11/2012
TENDER CLOSING TIME: 10.00 HOUR.
OFFICE OF THE
CONTROLLER OF STORES
D.L.W. VARANASI
Important Instructions to the Tenderers
Terms & Conditions
SPECIAL CONDITION: The supplier’s are requested to quote only branded medicines ‘Generic
medicines ‘ shall not be considered. Such offers quoting ‘Generic medicines ‘or’ Branded Generic
medicines’ shall be summirily ignored.”

Firm should clearly indicate the Tender Number & date of opening on the top of the envelop as in
the offer.

The rates should be typed or written in ink, both in words and figures. Correction, if any, should be
authenticated. The offer is liable to be ignored for any ambiguity in words and figures or
unauthenticated corrections. The offer should be clearly for items asked for in regard to
strength/volume of the item.

The validity of the offers should be 90 (ninety) days from the date of tender opening.
Firm should clearly quote the exact percentage of Sales Tax / VAT or any other taxes duties. In
case of Sales Tax / any other duties / taxes not existing PO, same shall not be admitted at the later
stage on any ground.

Manufacturer’s name, Brand name, Formulation & other key details of the product must be
indicated / attached in the offer. The firm should also clearly state that the drug offered is not
branded genric/generic.

Shelf life of medicines should be clearly mentioned in the offer for each item. Shelf life of
medicines at the time of the supplies should not be less than 80% of the total shelf life.

The procurement of medicines is as per new drug policy 2008, (as updated from time to time) of
Health Directorate of Indian Railways from approved lists only. The approved list and other details
are available on DLW’s website.

Direct Quotation received from the principal firm, to whom the tender enquiry has been sent, or of
its authorized dealer, only will be considered. However, direct quotations from OEMs /Principals
are solicited.

In case of offers from authorized dealers, the firm to whom the Tender enquiry has been sent must
furnish a specific Authorization certificate. The Performa for same is enclosed. In case the
authorized dealer is not available in the viscinity of Varanasi or nearby , the OEM’s should
authorized their regional office quoting & supplying the drug on firm’s behalf.

When offers are submitted by firms who are only marketing the product, such firms must indicate
the manufacturers name in their offers.

Latest authorization letter must be sent either in advance or along with the offer otherwise offer is
likely to be rejected. The name, designation and contact number ( for verification) of the person
who is issuing the authority should be clearly mentioned in the authorization letter.

The person who is authoring distributor to quote should also submit a product list for which items
they are authorized by the company for (generic / branded items). If there is any increase in prices
please submit the price list to the COS office, DLW, Varanasi.

One distributor/ agent, having more than one authorization, can quote only for one OEM /
Manufacturer against a tender. In case he quotes for

more than one authorized firm, all
offers of such tenderer are liable
to be rejected.
Containers/Package should have endorsement “Indian Railways (or DLW/IR) – Not for Sale”.
Medicines should be manufactured by the firm themselves which must be mentioned in labeling /
packing. If the principal firm is marketing the medicine manufactured by other firm then name of
principal firm must be endorsed in the packing of the product. Otherwise offer is not acceptable.

Packing offered should be such as to withstand rough handling, transportation and exposure to
extreme temperature and climatic conditions. Products do not which have paper packing are not
acceptable.

Drugs / Products of human origin should also have a certification stating “Free from HIV”,
“Hepatitis ‘B’” and “Hepatitis ‘C’”, E, Anti haemolytic factors immunoglobulin, Human Albumin etc.

The cost of sample testing analysis in the laboratories will be borne by the firm if found
unsatisfactory.

Delivery to be made to the Hospital Pharmacy Stores, Central Hospital, DLW, Varanasi, at the cost
and risk of the firm.

Inspection of medicines will be done at the Hospital Pharmacy Stores, Central Hospital, DLW,
Varanasi.

All rejected articles must be removed by the suppliers, at their own risks and costs within 7 days of
the rejection notice. If the rejected material is not removed within the specified period, the DLW
shall be at liberty to return the material on freight to pay basis to the firm without any further
reference. If in the opinion of the inspecting officers, the material is not worth returning, the same
shall be thrown away or destroyed. Neither claim of cost nor any compensation shall be
entertained against these items.

In case principal firm desire to effect the supply through its authorized dealer / supplier and
request this office to send the Purchase Order to the authorized dealer / supplier, all legal and
financial liabilities shall remain binding on the principal firm quoting rates.

The Railway Administration reserves the right to take samples of any items supplied for analysis.
Cost of the analysis will be borne by the supplier in case of unsatisfactory reports. Wherever, drug
samples on analysis are found to be not conforming to standard, the suppliers are required to
replace the whole quantity.

L.D. shall be leviable as per rules for delayed supplies.
Bill for 100% payment will be entertained after receipt and acceptance of the medicines/ items in
good and sound conditions.

The Railway Administration reserves the right to accept or reject any or all tenders, without
assigning any reason, thereto and no claim shall be entertained in this respect.

27. The manufacturer / principal firms are requested to send their current Hospital price list of their
products directly to the Controller of Stores, Diesel Locomotive Works, Varanasi and CMS
/DLW/Varanasi.

28. All other terms and conditions shall be as per IRS CONDITIONS OF CONTRACT, as updated from time
to time (available on the website of DLW).
OFFICE OF THE
CONTROLLER OF STORES
D.L.W. VARANASI
PROFORMA
The Controller of Stores,
Diesel Locomotive Works,
Varanasi-221004

SUB: Authorization to quote against the special medical
Bulletin No. Dated----------------
**********
We are forwarding the Special Medical bulletin No.______ Dated ________
to M/s. ________________________ to quote the competitive rates for our product,
obtain orders, make the supply on our behalf and collect the payment directly.
They are also advised to give the brake-up of the price quoted i.e. Basic price,
Sales tax and other charges if any cess elements should be shown separately.
Please note that no other party is authorized for quoting against the above
mentioned bulletin quotation from any other sources on our behalf be ignored.

M/s. _________________
__________________
--------------------------------
T.P.No._________________
FAX No.________________
GRAM _________________

The above certificate is only Specimen, therefore this certificate should be typed
on your original letter head dully signed by the head of the firm and same should
be sent to the COMTROLLER OF STORES, DIESEL LOCOMOTIVE WORKS, along
with offer and one copy separately also .

---------------
-------------

DIESEL LOCOMOTIVE WORKS, VARANASI
SCHEDULE OF REQUIREMENTS FOR BULLETIN:-
TENDER NO
DESCRIPTION OF STORES
DUE ON 05.07.2012
071231090
TAB ERYTHROMYCIN-500 MG.
071231100
TAB/CAP AMPICILLINE-250 MG. CLOXACILLINE/DICLUXACILLIN-250 MG.
071231110
TAB AZITHROMYCIN-100 MG.
071231120
TAB BALOFLOXACIN-100 MG.
071231130
TAB LINIZOLID-600 MG.
071231140
TAB/DT CEFEXIME-100 MG.
071231150
TAB CLOPIDOGREL-75 MG.
071231160
TAB ALPRAZOLAM-0.25 MG.
071231170
TAB ALPRAZOLAM-0.5 MG.
071231180
TAB HYDROCHLOROTHIAZIDE-12.5 MG.
071231190
TAB NEBIVOLOE-5 MG.
071231200
TAB ENALPRIL-5 MG.
071231210
TAB LOSARTAN POT-50 MG.
071231220
TAB LOSARTAN POT-50 MG. HYDROCHLOROTHIAZIDE-12.5 MG.
071231230
TAB METROPROLOL TARTRATE-50 MG.
DUE ON 09.07.2012
071231240
TAB ATORVASTIN-10 MG.
071231250
TAB ATORVASTIN-20 MG.
071231260
TAB ISORBIDE DINITRATE-10 MG.
071231270
TAB ISORBIDE-5-MONONITRATE-20 MG.
071231280
TAB AMIDARONE-200 MG.
071231290
TAB TELMESARTAN-20 MG.
071231300
TAB TELMESARTAN-40 MG. HYDROCHLOROTHIAZIDE 12.5 MG.
071231310
TAB VARAPAMIL-40 MG.
071231320
TAB TRIMETAZEDINE 20 MG.
071231330
TAB PROPANOLOL-40 MG.
071231340
TAB RAMIPRIL-2.5 MG.
071231350
TAB RAMIPRIL-5 MG.
071231360
TAB AMLODEPINE-5 MG.
071231370
TAB AMLODEPINE-5 MG. ATENOLOL-50 MG.
071231380
TAB CARVIDILOL-6.25 MG.
DUE ON 12.07.2012
071231390
TAB CARVIDILOL-12.5 MG.
071231400
TAB METROPROLOL SUCCINATE + AMLODEPINE-5 MG.
071231410
TAB ROSUVASTATIN-20 MG.
071231420
TAB ATENOLOL-50 MG.
071231430
TAB ACETXLESALICYLIC ACID-150 MG.
071231440
TAB QUITIAPIN-100 MG.
071231450
TAB GLIMPERIDE-1 MG.
071231460
TAB GLIMPERIDE-2 MG.
071231470
TAB METFORMINE HCL-500 MG.
071231480
TAB GLIPIZIDE-5 MG.
071231490
TAB MR/XR/SR METFORMINE HCL 1000 MG.
071231500
TAB DOXYFILLINE 400 MG.
071231510
R/CAP SALBUTAMOL SULFATE I.P-200 ug.
071231520
R/CAP FORMOTEROL FUMRATE-6 MCG. BUDESONIDE-200 MCG.
071231530
R/CAP TIOTROPIUM BR-18 MCG.
DUE ON 16.07.2012
071231540
R/CAP BUDESONIDE-400 MCG.
071231550
TAB URSODEOXYCHOLIC ACID-150 MG.
071231560
TAB ORLISTAT-120 MG.
071231570
TAB MEFENAMIC ACID-250 MG. DROTAVERIN
071231580
TAB. ACELOFENAC-100 MG. PARACETAMOL-500 MG.
071231590
TAB FINESTRIDE-5 MG.
071231600
TAB DUTESTRIDE-0.5 MG.
071231610
TAB FENOFIBRATE 160-200 MG.
071231620
TAB TIZANIDINE-2 MG.
071231630
TAB FLAVAXATE-200 MG.
071231640
TAB CR/CROMO SODIUMVALPORATE 333 MG. VALPORIC ACID-145 MG.
071231650
TAB OXYCARBAZINE 450 MG.
071231660
TAB OXYCARBAZINE 300 MG.
071231670
TAB DANAZOLE-100 MG.
071231680
TAB FOLLIC ACID-5
DUE ON 19.07.2012
071231690
TAB/CAP BROMOCROPTIN MESYLOTE-2.5 MG.
071231700
TAB CONJUGATED ESTROGENS.
071231710
TAB LIVOCETRIZINE-5 MG.
071231720
TAB PARACETAMOL-325-500 MG. DICLOFENAC SOD.-50 MG.
CHLORZOXONE-250-500 MG.
071231730
TAB/CAP GLUCOSAMINE SULPHATE-500 MG.
071231740
TAB FLUXETIN HCL-20 MG.
071231750
TAB XL/TR/SR. LITHIUM CARBONATE-400 MG.
071231760
TAB TRIFLUOPERAZINE-5 MG. TRIHEXYPHENIDYL-2 MG.
071231770
TAB TRIHEXYPHENEDYL 2 MG.
071231780
TAB SERTALINE-50 MG.
071231790
TAB LEVODOPA-250 MG. CARBIDOPA-25 MG.
071231800
TAB BISACODYL-5 MG.
071231810
INJ. EACH ML SUSPENSION CONTAINS 100 I.U.(3.5 MG) OF INSULIN
ASPART-R-DNA ORIGINJ 30% AS SOLUBLE INSULIN AS PART AND 70%
AS INSULIN AS PART PROTAMIN CRYSTAL. 3 ML PREFILLED PEN.

071231820
INJ. EACH ML CONTAINS 25% INSULIN LIPRO AND 75% INSULIN LIPRO
PROTAMIN. SUSPENSION. EACH PREFILLED PEN OF 3 ML.
DUE ON 23.07.2012
071231840
INJ. EACH PFS CONTAINS ENOXAPERIN-40 MG/0.4 ML.
071231850
INJ. EACH ML CONTAINS HUMAN INSULIN-40 I.U. VIAL OF 10 ML.
071231860
INJ. EACH 2 ML CONTAINS AMIKACIN-500 MG. VIAL OF 2 ML.
071231870
INJ. EACH VIAL CONTAINS CEFTRIAXONE-1 GM. TAZOBACTAM-125 MG.
071231880
INJ. EACH AMPULE CONTAINS NANDROLONE DECANOATE-25 MG.
071231890
INJ. EACH AMPULE CONTAINS NANDROLONE DECANOATE-50 MG.
071231900
INJ. EACH AMPULE CONTAINS IOTHALMATE-76% OR DIATRIAZONE
MAGLUMINE AND DIATRIZOATE SODIUM-76%.
071231910
INJ. EACH PFS CONTAINS ERYTHROPOIETIN-400 I.U.
071231920
INJ. EACH VIAL CONTAINS HYDROCORTISONE SUCCINATE-100 MG.
071231930
INJ. EACH ML CONTAINS ONDANSCTRON-2 MG. AMPULE OF 2 ML.
071231940
INJ. COMBIPNATION OF TWO AMPULE (a) EACH 1.5 ML AMPULE
CONTAINS VITAMIN-C-150 MG. (b) EACH ML CONTAINS VITAMIN B12-250
MCG, FOLIC ACID-0.7 MG. NIACINAMIDE-12 MG.

071231950
INJ. EACH AMPULE CONTAINS. THIAMIN-100 MCG + PYRIDOXIN-100 MG.
+RIBOFLAVIN-5 MG. + VITA-B 12-100 MCG. + NICOTINAMIDE-100 MG + D-
PAN THENOL-50 MG.-3 ML AMPULE.

071231960
INJ. EACH ML CONTAINS PROMETHAZINE-HCL-25 MG. AMPULE OF 2 ML.
071231970
INJ. EACH ML CONTAINS TRAMADOL HYDROCHLORIDE-50 MG. AMPULE
071231980
INJ. EACH PFS CONTAINS HYDROXYPROPYLMETHYLCELLULOSE-2%.
DUE ON 26.07.2012
071231990
INJ. EACH BOTTLE CONTAINS SODIUM CHLORIDE-0.9% BOTTLE OF
500-540 ML.
071232000
INJ. EACH BOTTLE CONTAINS RINGER LACTATE-BOTTLE OF 500-540 ML
071232010
INJ. EACH VIAL CONTAINS PANTOPRAZOLE-40 MG.
071232020
INJ. EACH VIAL CONTAINS VANCOMYCIN-500 MG.
071232030
INJ. EACH PFS CONTAINS HUMAN PAPILLOUMS VIRUS VACCINE
CANTAIN HPV TYPE 16L1, PROTIEN 20 MICROGRAM AND HPV TYPE-18L1
PROTEIN 20 MECROGRAMS WITH ADIUVANT-SYSTEM ASO4-0.5 ML.

071232040
SYP. EACH 5 ML CONTAINS AMOXYCILLINE -200 MG. CLAVULANIC ACID-
28.5 MG. 30-60 ML PH.
071232050
SYP. EACH 5 ML CONTAINS AZITHROMYCIN-200 MG. 15-30 ML PHAIL.
071232060
SYP. EACH 5 ML CONTAINS CEFACLOR-125 MG. 30 ML PHAIL.
071232070
SYP. EACH 5 ML CONTAINS CEFADROXIL-250 MG.
071232080
SYP. EACH 5 ML CONTAINS CEFPODOXIM-100 MG. 30-60 ML PH.
071232090
SYP. EACH 5 ML CONTAINS OFLOXACIN-50 MG. ORNIDAZOLE-125 MG. 30
ML PHAIL.
071232100
SYP. EACH 5 ML CONTAINS DISODIUM HYDROGEN CITRATE-1.53 GM.
PHAIL OF 100-120 ML.
071232110
SYP. EACH 15 ML CONTAINS MILK OF MAGNESIA-3.75 ML. LIQUID
PARAFTIN-11.25 ML. OR PHENOLPTHELIN-11.25 ML. BOTTLE OF 170-200
ML.

071232120
SYP. EACH 15 ML CONTAINS LACTULOSE-10 GM. BOTTLE OF 100-150 ML
071232130
SYP. EACH 15 ML CONTAINS LACTITOLE MONOHYDRATE-66.67%
BOTTLE OF 100-130 ML.
DUE ON 01.08.2012
071232140
SYP. EACH 5 ML CONTAINS IBUPROFIN-100 MG. PARACETAML-125 MG.
60 ML PHAIL.
071232150
EACH JAR CONTAINS GLUTARAL DEHYDE-2%-5% 28 DAYS LIFE. JAR OF
071232160
SOLUTION CONTAINS CHLOROXYLENOL-4.8% TENPINOL-9% ALCOHOL
ABSOLUTE-13.1%. 500 ML BOTTLE OF 5 LTR. JAR.
071232170
SYP. EACH 5 ML CONTAINS ONDANSETRON-2 MG. PHAIL OF 30 ML.
071232180
SYP. EACH 5 ML CONTAINS FEXOFENADINE-30 MG. PHAIL OF 60 ML.
071232190
SYP. EACH 5 ML CONTAINS SALBUTAMOL-2 MG. PHAIL OF 100-120 ML.
071232200
SYP. EACH 5 ML CONTAINS THEOPHYLIN-50 MG. + SALBUTAMOL-1 MG.
BOTTLE OF 60-100 ML.
071232210
SYP. EACH 5 ML CONTAINS BROMOHEXIN-4 MG. GUAPHENSIN-50 MG.
CHLORPHENERAMINE MALEATE-2 MG. BOTTLE OF 100 ML.
071232220
SYP. EACH 5 ML CONTAINS GUAPHENSIN-50-60 MG. TERBUTALIN-1.25-2
MG. BROMOHEXIN-2-4 MG + MENTHOL-0.5-1 MG, BOTTLE OF 100-120 ML.
071232230
SYP. EACH 5 ML CONTAINS DIPHENHYDRAMIN-14.08 MG. AMMONIUM
CHLORIDE-138 MG + SODIUM CITRATE-57 MG. MENTHOL-1.14 MG.
BOTTLE OF 100-120 MG.

071232240
SYP. EACH 5 ML CONTAINS. CHLORPHENIRAMINE MALEATE-2.5-3 MG. +
AMMONIUM CHLORIDE-125 MG-150 MG + SODIUM CITRALE-55-60 MG.
BOTTLE OF 100-120 MG.

071232250
SYP. EACH 5 ML CONTAINS DEXTROMETHORPHAN-10 MG.
CHLORPHENIRAMINE MALEATE-4 MG. PHAIL OF 50-100 ML.
071232260
SYP. EACH 10 ML CONTAINS SUCRALFATE-1 GM. BOTTLE OF 100-200 ML
071232270
EACH BOTTLE MOUTH WAS CONTAINS BENZADAMINE-0.15% W/V.
BOTTLE OF 100-150 ML.
071232280
EACH BOTTLE MOUTH WASH CONTAINS THYMOL-0.06% + EUCALYPTAL
OIL -0.09% + MENPHOL-0.04% PHAIL OF 85-120 ML.
DUE ON 06.08.2012
071232290
EACH MOUTH WASH CONTAINS CHLORHEXIDINE-0.2% W/V. PHAIL OF
100-120 ML.
071232300
SYP. EACH 5 ML CONTAINS ELEMENTAL CALCIUM-125 MG +V ITA-D3-
62.5 MG.CAGNESIUM- 10 MG ,MANGANESE-0.5 MG , BORAX-2.5 MG, ZINC-
2.5 MG BOTTLE OF 150.

071232310
EYE DROP CONTAINS OFLOXACIN-0.3% PHAIL OF 5-10 ML.
071232320
EACH EYE DROP CONTAINS TOBRAMYCIN-0.3% PHAIL OF 5-10 ML.
071232330
EACH EYE ONT CONTAINS TOBRAMYCIN-0.3% TUBE OF 3-10 GM.
071232340
EACH OPTHO-CAP CONTAINS CHLORAMPHENICAL-1%.
071232350
EACH EYE DROP CONTAINS FLURBIPROFIN-0.03% PHAIL-5-10 ML.
071232360
EACH EYE DROP CONTAINS KETOTIFIN-0.5 MG. PHAIL OF 5-10 ML.
071232370
EACH EYE DROP CONTAINS TIMOLOL- 0.5% PHAIL OF 5-10 ML.
071232380
EACH EYE DROP CONTAINS TROPICAMIDE-0.8% PHENYLEPHIRINE-HCL-
5% PHAIL OF 5-15 ML.
071232390
EACH EYE DROP CONTAINS POLYVINYL ALCOHOL-1.4% POVIDONE-0.6%
PHAIL OF 5-10 ML.
071232400
EACH EYE DROP CONTAINS MOXIFLOXACIN-0.5% PHAIL OF 5-10 ML.
071232410
EACH EYE DROP CONTAINS MOXIFLOXACIN-0.5% PREDNISOLONE
ACCTALE-1% PHAIL OF 5-10 ML.
071232420
EACH EYE DROP CONTAINS MOXIFLOXACIN-0.5% KCTORALAC. PHAIL
OF 5-10 ML.
071232430
EACH EYE DROP CONTAINS SODIUM CARBOXYMETHYL. CELLULOSE-0.5
MG. PHAIL OF 5-10 ML.
DUE ON 09.08.2012
071232440
EACH EYE DROP CONTAINS NAPHAZOLIN-0.056% CHLORPHENIRAMIN
MALEATE-0.01% PHAIL OF 5-10 ML.
071232450
EACH NASAL SPARY CONTAINS BUDISONIDE-64 MCG PER 1 DOSE 200
METRE DOSE.
071232460
EACH NASAL SPARY CONTAINS FLUTICASONE PROPIONATE-0.05% 100
METERED DOSE
071232470
EACH EAR DROP CONTAINS CHLORAMPHENICOL-5%,
BECLOMETHASONE DIPROPIONATE-0.025%, CLOTRIMAZOLE-1%,
LIDOCAINE-1.73%. PHAIL OF 5-10 ML.

071232480
EACH EAR DROP CONTAINS. PARADICHLOROBENZINE-2%,
BENZOCAINE-2.7%, CHLOROBUTANOL-5%, TURPENTINE OIL-15%. PHAIL
OF 5-10 PH.

071232490
EACH INHALER CONTAINS. LEVOSALBUTAMOL-100 MCG/1 PUFF 200
METERD DOSE (CFC FREE).
071232500
EACH INHALER CONTAINS BUDESONIDE-100 MCG/PUFF 100 METERED
DOSE. (CFC FREE).
071232510
EACH INHALER CONTAINS TIOTROPIUM BROMIDE-9 MCG/PUFF. 120
METER DOSE CONSTER. (CFC FREE).
071232520
EACH INHALER CONTAINS. BUDESONIDE-400 MCG. FORMOTEROL-
FUMARATE-6 MCG/PER PUFF, 120 METERED DOSE CONSTER (CFC FREE)
071232530
CREAM CONTAINS BETAMETHASONE DIPROPIONALE-0.025% TUBE OF
12-25 GM.
071232540
CREAM CONTAINS BECLOMETHASONE DIPROPIONALE-0.025%,
NEOMYCIN-0.5%. TUBE OF 15-20 GM.
071232550
CREAM CONTAINS BETAMETHASONE-0.025%. SALICYLIC ACID-3%. TUBE
OF 15-20 GM.
071232560
CREAM CONTAINS MICONAZOLE-2%. TUBE OF 15-20 GM.
071232570
CREAM CONTAINS CLOTRIMAZOLE-1%. BECLOMETHASONE-
DIPROPIONATE-0.025%. TUBE OF 10-20 GM.
071232580
EACH CREAM CONTAINS FUSIDIC ACID-2%. TUBE OF 5-15 GM.
071232590
EACH CREAM/ONT. CONTAINS MUPIROCIN-2%. TUBE OF 5-20 GM.
DUE ON 17.08.2012
071232600
@ EACH CREAM CONTAINS CLOBETASOL PROPIONATE-0.05%. TUBE OF
10-12 GM.
071232610
EACH CREAM CONTAINS FRAMYCETIN SULPHATE-1%. TUBE OF 20-30
071232620
EACH CREAM CONTAINS FRAMYCITIN SULPHATE-1%.
DECXAMETHASONE ACETATE—0.1%. CLOTRIMAZOLE-1%. TUBE OF 20-
30 GM.

071232630
EACH GEL CONTAINS. DICLOFENAC-1%. TUBE OF 15-30 GM.
071232640
EACH GEL CONTAINS PIROXICAM-0.5%. TUBE OF 15-30 GM.
071232650
JELLY CONTAINS LIDOCAINE-2%. TUBE OF 10-20 GM.
071232660
EACH CREAM/ONT CONTAINS BIFONAZOLE-1%. TUBE OF 10-20 GM.
071232670
EACH ONT CONTAINS HYDROCORTISONE ACETATE-5.58 MG.,
FRAMYCETIN SULPHATE-10 MG. HEPARIN-100 I.U. ESCULOSIDE-10 MG.
ETHYLAMINOBENZOATE-10 MG, BUTYLAMMINOBEZOATE-10 MG. TUBE
OF 10-20 GM.

071232680
EACH NASAL DROP CONTAINS XYLOMETAZOLINE-0.05%. PHAIL OF 10-15
071232690
EACH NASAL DROP CONTAINS XYLOMETAZOLINE-0.1%. PHAIL OF 10-15
DUE ON 21.08.2012
071232700
EACH INHALER CONTAINS. FLUTICASONE PROPIONATE-250 MCG.
SALMETEROL-50 MCG/PUFF 120 METERED DOSE PER COSTER. (CFC
FREE).

071232710
INJ EACH ML CONTAINS 100U. INSULIN DETEMIR (R-DNA ORIGIN) 14.2
MG. 3 ML PFS.
071232720
INJ EACH ML SOLUTION CONTAINS 100 U (3.5 MG) OF INSULIN ASPART.
(r-DNA ORIGIN). 3 ML PFS.
071232730
SYP. EACH 10 ML CONTAINS ACTIVATED DIMETHICON. HYDROXIDE-100-
250 MG + DRID ALLUMINIUM HYDROXIDE-150-250 MG + SORBITOL
SOLUTION-75%. BOTTLE OF 170-200 ML.

071232740
SYP. EACH 10 ML CONTAINS MAGNESIUM HYDROXIDE-185 MG +
SIMETHICENE-50-100 MG.+ SODIUM CARBOXYMETHYLCELLULOSE-100
MG + DRIED ALUMINIUM HYDROXIDE GEL-830-1000 MG. BOTTLE OF 170
ML-200 ML.

071232750
SYP. EACH 15 ML CONTAINS FERRIC AMMONIUM CITRATE-150-160 MG.
FOLIC ACID-0.5-1.5 MCG. VIT B12-7.5-15 MCG. BOTTLE OF 200 ML.
071232760
SYP. EACH 15 ML CONTAINS. THIAMIN-2-4 MG., RIBOFLAVIN -2.54 MG. +
PYRIDOXIN-2 MG., NIACINAMIDE-20 MG., D-PANTHENOL-6 MG. +
ASCORBIC ACID-75 MG. BOTTLE-100-200 ML.

071232770
INJ. EACH ML CONTAINS RABIES ANTIGEN >- 2.5 I.U. ADSORBED ONTO
ALUMINIUM PHASPHATE. ADAPTED AND GROWN ON HUMAN DIPLOID
CELLS & INACTIVATED BY USING B. PROPIOLACTONE.

DUE ON 24.08.2012
071232780
TAB CEFEXIME-200 MG.
071232790
TAB/CAP. AMOXYCILLIN-500 MG. CLAVULANIC ACID-12.5 MG.
071232800
TAB. CEFEXIME-200 MG. OFLOXZCIN-200 MG.
071232810
TAB. CLARITHROMYCIN-500 MG.
071232820
TAB ATORVASTIN-40 MG.
071232830
TAB/GIT/ORS PRAZOCIN-2.5 MG.
071232840
TAB/GIT/ORS PRAZOCIN-5 MG.
071232850
TAB PERINDOPRIL-4 MG. AMLODEPINE-5 MG.
071232860
TAB TELMESARTAN-40 MG.
071232870
TAB. NICORANDIL-5 MG.
071232880
TAB/SR. GALENIC FORMULAION BASED ON HYDROPHILIC MATRIX
INDOPAMIN SR-1.5 MG.
071232890
TAB OLMESARTAN-40 MG.
071232900
TAB SEXAGLIPTIN-5 MG.
071232910
TAB URSODEOXYCHOLIC ACID-300 MG.
071232920
TAB/CAP TAMSULOSIN HCL 0.4 MG.
071232930
TAB/CAP. TAMSULOSIN-0.4 MG. DUTESTRIDE-0.5 MG.
071232940
TAB VIT B1-15 MCG, B1-10 MG B2-10 MG. NICOTINAMIDE-100 MG,
CALPANTHONATE 10 MG.-12.50 MG., B6-3 MG.FOLLIC ACID-1.5 MG. VITC-
150 MG.

071232950
TAB. FEXOFENADINE-120 MG.
071232960
TAB TRYPSIN-CHYMOTRY-PSIN-2 LAKHS. ARMOUR UNIT OF ENRY MATIC
ACTIVITY.
071232970
DIOSMIN-450 MG. HESPERIDON-50 MG.
071232980
TAB. ATORVASTIN-80 MG.
071232990
TAB TRYPSIN/CHYMOLRYPSIN-50,000 I.U. DICLOFENAC SOD-50 MG.
DUE ON 27.08.2012
071233000
TAB/CAP PRIMOSAOIL-1000 MG.
071233010
TAB HYDROXYZINE HCL-25 MG.
071233020
TAB/R MEBEVERINE HCL/R.
071233030
TAB PHENTOIN SOD-100 MG.
071233040
TAB TRIBASIC CAL. PHOSPHOTE -0.38 GRAM eg CALCIUM-125 MG +VIT
D3-400 I.U.
071233050
TAB TRAMADOL HCL-37.5 MG ACETAMINOPHEN-325 MG.
071233060
TAB ACETAZOLAMIDE 250 MG
071233070
TAB CINRAZINE-75 MG
071233080
TAB PROCHLORPERAZINE-5MG
071233090
TAB LAMOTRIZINE-50 MG
071233100
TAB METHYLCOBALAMINE-1500 MG
071233110
TAB THIOCOLCHICOSIDE -4 MG DICLOFENAC-50 MG
071233120
TAB GABAPENTIN-300 MG
071233130
TAB THYROXIN SOD -100 MG
071233140
TAB THYROXIN SOD-50 MG
071233150
TAB THYROXIN SOD-25 MG
DUE ON 29.08.2012
071233160
TAB SALAZOPYRIN-500-1000 MG
071233170
TAB ACETYLE SALIEYLIC ACID-75 MG
071233180
CAP FERROUS FUMRATE-200 MG FOLLIC ACID-0.3 MG VIT B12-10 MCG,
ZNSO4-6.18 MG
071233190
TAB PIRACETAM 800-1200 MG
071233200
TAB ZINKGOBILOBA 40 MG
071233210
TAB ELEMENTAL CALCIUM -500 MG VIT D3 -250 IU
071233220
TAB SODIUM ALENDRONATE-70 MG
071233230
TAB DEFAZACORT -6 MG
071233240
TAB ACICLOVIR-800 MG
071233250
TAB CARBAMAZEPINE-200 MG
071233260
TAB/SR CARBAMAZEPINE 200MG
071233270
TAB PENTAPERAZOLE-40 MG DOMPERIDON-10 MG
071233280
TAB LAMITHINE-L ASPARATE-150MG
071233290
TAB RANOLAZINE-500 MG
071233300
FERROUS FUMRATE-152 MG, FOLLIC ACID-1500 MCG
DUE ON 03.09.2012
071233310
TAB ALFACALCIDOL-0.25MG
071233320
TAB OXYCARBAZINE 600 MG
071233330
TAB CLONIDINE-100 MCG
071233340
TAB BETAHISTADIN-48 MG
071233350
TAB ALISKIRAN-150 MG
071233360
TAB GLIMPERIDE-4MG METFORMINE HCL-500 MG
071233370
TAB BETAHISTADIN -16 MG
071233380
TAB/CAP LANSOPRAZOLE-30 MG
071233390
TAB TEDROXY PROGESTERIN -10 MG
071233400
TAB CLONAZEPAM-0.5 MG
071233410
TAB DRIED AL. HYDROXIDE GEL-300 MG + AL. SILICATE-50MG+
SEMITHICON -25MG + MG. HYDROXIDE-25MG
071233420
TAB NORTHESTERON-5MG
071233430
TAB CHLORODIOAZEPOXIDE CLIDINIUM BR-
071233440
TAB CITICOLINE-500 MG
DUE ON 06.09.2012
071233450
TAB CLOBAZAM-10MG
071233460
TAB DONEPEZIL-5-10MG
071233470
TAB VOGLIBOSE-0.2MG
071233480
TAB. VOGLIBOSE-0.3MG
071233490
SACCHET EACH SACCHET CONTAINS CHOLECALCIFEROL-1 G.
071233500
TAB. PIOGLITAZONE-15 MG.
071233510
CAP/TAB. EACH HARD GELATIN CAP. CONTAINS- SPORES OF POLYANTI
BIOTIC RESISTANT BASILLUS CLAUSI-2 BILLION.
071233520
TAB. MONTELUKAST SOD-10 MG. LIVOCETRIZINE-5 MG.
071233530
TAB. NICOUMALONE-I.P.-1 MG.
071233540
TAB. CLOBAZAM-5 MG.
071233550
TAB. MEFLOQUINE-100 MG.
071233560
TAB. TRENEXAMIC ACID-500 MG. MEFENAMIC ACID-500 MG.
071233570
TAB. RAMIPRIL-2.5 MG. HYDROCHLOROTHIAZIDE-12.5 MG.
DUE ON 10.08.2012
071233580
TAB CARBAMAZOLE-5 MG.
071233590
TAB PANTAPERAZOLE-40 MG.
071233600
TAB/KIT MISOPROSTOL-200 MCG.
071233610
TAB/KIT MIFEPROSTONE-200 MCG.
071233620
TAB GAMFIBROZIL-300 MG.
071233630
SACCHET. 3 GRAM PKT CONTAINS L-OMITHIN-L-ASPARATE-5 G.
071233640
TAB ZOLPIDEM 12.5 MG.
071233650
TAB ETOFYLLINE-115 MG. THEOPHYLLINE-35 MG.
071233660
TAB MONTEULOKAST-10 MG. FEXOFENADONE-120 MG.
071233670
TAB/M/D. ONDENSTERON-4 MG. (M/D. TABLET).
071233680
TAB CLOPIDOGREL-75 ACETYLE-SALICYLIC ACID-75 MG.
071233690
SYP. 5 ML CONTAINS CHLORPHENIRAMINE-MALEAT-40-50 MG.+ CODINE
PHOSPHATE-10-15 MG. PHAIL OF 100-150 ML.
071233700
SYP. EACH 5 ML CONTAINS LEVOCLOPERASTINE-FENDIZOATE-35.4 MG.
+ ASPARTARNE-8 MG. PHAIL OF 100-120 ML.

Source: http://www.dlw.indianrailways.gov.in/works/uploads/File/e.pdf

Neue antikonvulsiva fortbildungsreferat bei der kreisärzteschaft calw am 6. november 2002

Fortbildungsreferat bei der Kreisärzteschaft Calw am 6. November 2002 Einleitung: In den letzten Jahren wurden 8 neue Antikonvulsiva mit unterschiedlichen Wirkmechanismen zu Behandlung von epileptischen Anfällen im Erwachsenenalter zugelassen. Die Indikation lautet in der Regel: Zusatz-Behandlung („add-on“) von komplex-fokalen Anfällen, die schwierig einzustellen sind. Wenige Medika

i am going to listen to radio

A. Short answers to yes/no questions: Instructions: In these dialogues, the long answer is given in parentheses. Look at the long answer and then write the appropriate yes/no question and short answer to complete each dialogue. Do not use a negative verb in the question. Example : A: Do you know my brother? B: No, I don’t. (I don’t know your brother.) 1. A: ______

© 2010-2017 Pdf Pills Composition